Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage

A Nehmé1, B L Lee, R Baskaran

  • 1Department of Medicine, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA, 92093-0058, USA.

British Journal of Cancer
|October 25, 2000
PubMed

Insights

Microtubule damage from paclitaxel activates c-Abl tyrosine kinase, enhancing cell death and G2/M arrest. This process relies on p21(WAF1) but not MAPK signaling in 3T3 cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • DNA damage is known to activate c-Abl tyrosine kinase.
  • Microtubule damage can also trigger cellular stress responses.

Purpose of the Study:

  • To investigate the role of c-Abl tyrosine kinase in response to microtubule damage induced by paclitaxel.
  • To elucidate the downstream signaling pathways involved in paclitaxel-induced cellular effects mediated by c-Abl.

Main Methods:

  • Utilized 3T3 cell lines with varying Abl kinase proficiency.
  • Administered paclitaxel to induce microtubule damage.
  • Assessed cell death, G2/M cell cycle arrest, p21(WAF1) expression, p53 expression, and MAPK phosphorylation.

Main Results:

  • Paclitaxel-induced microtubule damage activates c-Abl kinase.
  • c-Abl kinase presence enhances paclitaxel-induced cell death in 3T3 cells.
  • Abl-proficient cells exhibit prolonged G2/M arrest and increased p21(WAF1) expression compared to Abl-deficient cells.
  • Paclitaxel's effects on G2/M arrest and p21(WAF1) are dependent on c-Abl kinase activity and p21(WAF1) expression, independent of p53 and MAPK pathways.

Conclusions:

  • c-Abl tyrosine kinase plays a crucial role in facilitating cell death and regulating G2/M arrest in response to paclitaxel-induced microtubule damage.
  • The c-Abl-mediated pathway involves p21(WAF1) but is independent of MAPK signaling.
  • These findings highlight a novel role for c-Abl in microtubule integrity and cell cycle control.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...